PCa Imaging retweeted
Fantastic opening session for the #CARRFS & @CanRadJournal Research Series last week, thanks to @brucebforster, Dr. Clarke, & Dr. Reinhold.
Next one coming up this Wed: Data collection with @NickSchiedaMD & @Christian_vdP
Register here: forms.gle/n3etwM4ARtuHGv1k8 @CARadiologists
PCa Imaging retweeted
Which patients have benefit of PSMA-PET/CT in addition to MRI in the primary diagnosis setting?
Read more 👇
prostate.uroonco.uroweb.org/…
#prostatecancer
@declangmurphy @DrDanielMoon @drlouiseemmett @DrMHofman @ButeauJames @OmarAlghazo86
@nathanoverseas @roodvdb
PCa Imaging retweeted
Comparison of Multi-Parametric MRI of the Prostate to 3D Prostate Computer Aided Designs and 3D-Printed Prostate Models for Pre-Operative Planning of Radical Prostatectomies: A Pilot Study sciencedirect.com/science/ar… #prostateMRI #prostatecancer #medtwitter
PCa Imaging retweeted
AI in urology: The future is improved outcomes #AUA21 @jaimelandmanuci @AjhungMD
Here is a take home summary auadailynews.org/home/articl…
PCa Imaging retweeted
MUSIC presentations at Day 4 of #AUA2021 are listed below!
#AUA21 #Prostate #KidneyCancer #KidneyStones #ROCKS #RenalMass #PCa #ProstateCancer
PCa Imaging retweeted
Better lesion conspicuity translates into improved prostate cancer detection: comparison of non-parallel-transmission-zoomed-DWI with conventional-DWI
link.springer.com/article/10… #prostateMRI #prostatecancer #medtwitter #CancerResearch
PCa Imaging retweeted
Thank you, @CORDIS_EU for updating the PIONEER project profile: cordis.europa.eu/project/id/…!
PCa Imaging retweeted
#AUA21 @AmerUrological Dr Evan Yu from Univ of Washington on the virtual podium now on update with M1 CRPC
Going on now #AUA21 @AmerUrological Instructional Course on Advanced Prostate Cancer with @JuddMoul Dr Larry Karsh and Dr Evan Yu Please join us!
PCa Imaging retweeted
Tune in NOW for the #AUA21 International Prostate Forum for a fantastic program with the latest evidence and practice in #ProstateCancer - starting with our panel on screening & genetic risk assessment aua2021.app.swapcard.com/eve…
PCa Imaging retweeted
Engaging debate on transperineal versus transrectal prostate biopsy @peterchiu_uro @LondonProstate1 @arvinkgeorge @ThomasPolascik @DrRastinehad “What would urologists choose for yourself or your family member?” #AUA21
PCa Imaging retweeted
The Additive Diagnostic Value of PSMA PET-CT to mpMRI Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study
buff.ly/3ymlXh3
@drlouiseemmett @DrMHofman @declangmurphy @lawrentschuk @DrHWoo @DrVenuC
PCa Imaging retweeted
Diagnostic Performance of 68Ga PSMA PET/MRI Compared with mpMRI for Detecting Clinically Significant Prostate Cancer pubs.rsna.org/doi/10.1148/ra…
"important study from 🇮🇱 showing benefit of use of PSMA PET in PIRADS 3 lesions at mpMRI" #prostatecancer #molecularimaging #CancerResearch
PCa Imaging retweeted
CHEERS trial at #ESTRO2021 presented by @MathieuSpaas: IO vs IO+SABR. Up to 3 lesions received 3x8Gy => no effect on PFS, clearly safe. Say “bye, bye to the “abscopal”-effect or did we do smth wrong? Supported by @komop_tgkanker @VarianMedSys – at Brugelette, Belgique
AJR webinar with USA study team from @OHSURadiology with @AJR_Radiology @NickSchiedaMD @SAR_ProstateDFP @LetDdiceFlyHigh @lkayat @Purysko @acw_rad @DoctorMargolis @claretempany @SilviaChangMD @tharakbathala @arosenkrantzmd @VermaSadhna @radiolobt
Wednesday's webinar will review an original research article which compares in-bore to fusion biopsy in PI-RADS category 4 and 5 lesions at a single-center with propensity scoring.
arrs.org/ajrlive
PCa Imaging retweeted
Wednesday's webinar will review an original research article which compares in-bore to fusion biopsy in PI-RADS category 4 and 5 lesions at a single-center with propensity scoring.
arrs.org/ajrlive
How many prostate MRI exams a radiologist should read annually to become an expert? @JelleBarentsz @VPanebiancoIT @MRIPRO1 @ProfPadhani @Tristan_Radiol @giga_fra
25%100
30%200
35%500
11%1000
170 votes • Final results









































